Market cap
$1,340 Mln
Recently Viewed
Clear AllMarket cap
$1,340 Mln
Revenue (TTM)
$1,145 Mln
P/E Ratio
22.6
P/B Ratio
33.7
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$63 Mln
ROE
1 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
7.2
Debt to Equity
11.3
Book Value
$1
EPS
$1.7
Face value
--
Shares outstanding
35,741,300
CFO
$971.09 Mln
EBITDA
$835.39 Mln
Net Profit
$236.72 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Apria (APR)
| 15.0 | 0.4 | 21.7 | 19.1 | -- | -- | -- |
|
BSE Sensex*
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Apria (APR)
|
37.5 | 1,340.3 | 1,145.3 | 64.9 | 8.8 | 969.2 | 22.6 | 33.7 |
| 7.9 | 5,292.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 1.0 | |
| 299.5 | 8,082.3 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10.8 | 1.1 | |
| 37.1 | 6,195.5 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.4 | |
| 121.7 | 7,074.2 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.8 | |
| 84.0 | 5,456.9 | 1,541.6 | 233.6 | 21.6 | 21.4 | 24.6 | 5.0 | |
| 178.6 | 9,341.0 | 1,526.9 | -151.5 | 20.0 | -17.1 | 46.6 | 12.9 | |
| 330.6 | 13,067.9 | 1,403.7 | 177.7 | 14.7 | 13.8 | 73.7 | 9.1 | |
| 117.1 | 7,400.2 | 738.3 | 48.9 | 11.4 | 2.4 | 150.8 | 3.5 | |
| 31.5 | 13,623.0 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.3 | 2.6 |
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators;... obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc. Read more
CEO & Director
Mr. Daniel J. Starck
CEO & Director
Mr. Daniel J. Starck
Headquarters
Indianapolis, IN
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Apria Inc (APR) is $37.50 (NASDAQ) as of 07-Apr-2022 09:30 EDT. Apria Inc (APR) has given a return of 19.12% in the last 1 years.
The P/E ratio of Apria Inc (APR) is 22.59 times as on 07-Apr-2022.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
19.09
|
31.18
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
The 52-week high and low of Apria Inc (APR) are Rs -- and Rs -- as of 25-Apr-2026.
Apria Inc (APR) has a market capitalisation of $ 1,340 Mln as on 07-Apr-2022. As per SEBI classification, it is a company.
Before investing in Apria Inc (APR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.